Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy

OBJECTIVE: This study was undertaken to characterize antiseizure medication (ASM) treatment pathways in Medicare beneficiaries with newly treated epilepsy. METHODS: This was a retrospective cohort study using Medicare claims. Medicare is the United States' federal health insurance program for p...

Descripción completa

Detalles Bibliográficos
Autores principales: Terman, Samuel W., Youngerman, Brett E., Choi, Hyunmi, Burke, James F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314094/
https://www.ncbi.nlm.nih.gov/pubmed/35294775
http://dx.doi.org/10.1111/epi.17226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314094/
https://www.ncbi.nlm.nih.gov/pubmed/35294775
http://dx.doi.org/10.1111/epi.17226

Ejemplares similares